Novel Blood, Tissue and Imaging Biomarkers for Pancreatic Cancer

Byeon, Sooin

Access status:

Open Access

Field	Value	Language
dc.contributor.author	Byeon, Sooin
dc.date.accessioned	2024-07-10T05:00:20Z
dc.date.available	2024-07-10T05:00:20Z
dc.date.issued	2024	en
dc.identifier.uri	https://hdl.handle.net/2123/32773
dc.description	Includes publication
dc.description.abstract	Pancreatic ductal adenocarcinoma (PDAC) is one of the most common types of pancreatic cancer. However, it has one of the most dismal survival outcomes of all major cancers and is projected to become the second most common cause of cancer-related deaths by 2030. Due to its asymptomatic feature and poor prognostic outcomes for most patients, identifying biomarkers for early diagnosis, prognosis, and prediction of treatment response could lead to the development of optimised treatment plans for PDAC patients. This thesis focused on identifying changes in biometals, proteins, and imaging parameters as potential biomarkers and drug targets with the aim to develop novel optimised treatment regimens for PDAC patients.	en
dc.language.iso	en	en
dc.rights	Copyright All Rights Reserved	en
dc.subject	pancreatic ductal adenocarcinoma	en
dc.subject	pancreatic cancer	en
dc.subject	biomarker	en
dc.subject	metal	en
dc.subject	protein	en
dc.subject	PET	en
dc.title	Novel Blood, Tissue and Imaging Biomarkers for Pancreatic Cancer	en
dc.type	Thesis
dc.type.thesis	Masters by Research	en
dc.rights.other	The author retains copyright of this thesis. It may only be used for the purposes of research and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission.	en
usyd.faculty	SeS faculties schools::Faculty of Medicine and Health::Northern Clinical School	en
usyd.degree	Master of Philosophy M.Phil	en
usyd.awardinginst	The University of Sydney	en
usyd.advisor	Sahni, Sumit	en
usyd.include.pub	Yes	en